Jay Rughani is a partner on the Bio investing team, where he focuses on companies that use software and data to accelerate medical research, streamline healthcare operations, and enable people to live healthier and happier lives.
Prior to a16z, Jay was an early team member at Flatiron Health (acquired by Roche). There, he helped to build some of the company’s first software and data products used by biopharmaceutical companies to examine real-world cancer care. As the business found product-market fit, he went on to lead numerous commercial partnerships with large biopharma companies, smaller biotechs, and other research organizations.
Previously, Jay advised large healthcare and technology organizations on corporate growth initiatives at Deloitte and managed various go-to-market, product, and capital raising initiatives at DealerMatch (acquired by Cox Enterprises).
Jay received a B.A. in Mathematics and Economics at Emory University and grew up in Clearwater, FL and London, UK.